Standardized method for in vitro antifungal susceptibility testing of Candida albicans biofilms

被引:599
作者
Ramage, G
vande Walle, K
Wickes, BL
López-Ribot, JL
机构
[1] Univ Texas, Hlth Sci Ctr, Dept Med, Div Infect Dis,S Texas Ctr Biol Med, San Antonio, TX 78245 USA
[2] Univ Texas, Hlth Sci Ctr, Dept Microbiol, San Antonio, TX 78245 USA
关键词
D O I
10.1128/AAC.45.9.2475-2479.2001
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Candida albicans is implicated in many biomaterial-related infections. Typically, these infections are associated with biofilm formation. Cells in biofilms display phenotypic traits that are dramatically different from those of their free-floating planktonic counterparts and are notoriously resistant to antimicrobial agents. Consequently, biofilm-related infections are inherently difficult to treat and to fully eradicate with normal treatment regimens. Here, we report a rapid and highly reproducible microtiter-based colorimetric assay for the susceptibility testing of fungal biofilms, based on the measurement of metabolic activities of the sessile cells by using a formazan salt reduction assay. The assay was used for in vitro antifungal susceptibility testing of several C. albicans strains grown as biofilms against amphotericin B and fluconazole and the increased resistance of C albicans biofilms against these antifungal agents was demonstrated. Because of its simplicity, compatibility with a widely available 96-well microplate platform, high throughput, and automation potential, we believe this assay represents a promising tool for the standardization of in vitro antifungal susceptibility testing of fungal biofilms.
引用
收藏
页码:2475 / 2479
页数:5
相关论文
共 40 条
[31]   THE BIOFILM GLYCOCALYX AS A RESISTANCE FACTOR [J].
HOYLE, BD ;
JASS, J ;
COSTERTON, JW .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1990, 26 (01) :1-5
[32]   PRODUCTION OF MUCOID EXOPOLYSACCHARIDE DURING DEVELOPMENT OF PSEUDOMONAS-AERUGINOSA BIOFILMS [J].
HOYLE, BD ;
WILLIAMS, LJ ;
COSTERTON, JW .
INFECTION AND IMMUNITY, 1993, 61 (02) :777-780
[33]   PSEUDOMONAS-AERUGINOSA BIOFILM AS A DIFFUSION BARRIER TO PIPERACILLIN [J].
HOYLE, BD ;
ALCANTARA, J ;
COSTERTON, JW .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1992, 36 (09) :2054-2056
[34]   Riddle of biofilm resistance [J].
Lewis, K .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2001, 45 (04) :999-1007
[35]   Expression of the multiple antibiotic resistance operon (mar) during growth of Escherichia coli as a biofilm [J].
Maira-Litrán, T ;
Allison, DG ;
Gilbert, P .
JOURNAL OF APPLIED MICROBIOLOGY, 2000, 88 (02) :243-247
[36]  
NATIONAL COMMITTEE FOR CLINICAL LABORATORY STANDARDS-NCCLS, 1997, M27A NCCLS
[37]   Development of interpretive breakpoints for antifungal susceptibility testing: Conceptual framework and analysis of in vitro in vivo correlation data for fluconazole, itraconazole, and Candida infections [J].
Rex, JH ;
Pfaller, MA ;
Galgiani, JN ;
Bartlett, MS ;
EspinelIngroff, A ;
Ghannoum, MA ;
Lancaster, M ;
Odds, FC ;
Rinaldi, MG ;
Walsh, TJ ;
Barry, AL .
CLINICAL INFECTIOUS DISEASES, 1997, 24 (02) :235-247
[38]  
Schierholz JM, 1999, ZBL BAKT-INT J MED M, V289, P165
[39]   Biofilms [J].
Stickler, D .
CURRENT OPINION IN MICROBIOLOGY, 1999, 2 (03) :270-275
[40]   INNOVATIVE END-POINT DETERMINATION SYSTEM FOR ANTIFUNGAL SUSCEPTIBILITY TESTING OF YEASTS [J].
TELLIER, R ;
KRAJDEN, M ;
GRIGORIEW, GA ;
CAMPBELL, I .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1992, 36 (08) :1619-1625